Trends in Pediatric Cancer Care in Florida From 1981-2020: Changing Patterns in a Growing and Increasingly Diverse Population.

cancer epidemiology cancer incidence clinical trial enrollment healthcare disparity pediatric cancer

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2023
Historique:
accepted: 16 02 2023
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 21 3 2023
Statut: epublish

Résumé

Background The Florida Association of Pediatric Tumor Programs (FAPTP) has used the Statewide Patient Information Reporting System (SPIRS) since 1981 to track all new cases of pediatric cancer. We reviewed the last 40 years of data to see how pediatric cancer care has evolved. Methods We retrospectively analyzed SPIRS data from 1981 through 2020 in five-year increments, looking at numbers of new diagnoses, care delivery sites, and trial enrollment in Children's Oncology Group (COG) studies. Results From 1981-2020 Florida's population increased almost 88% while the pediatric population only grew 61%. New pediatric cancer diagnoses increased 326% to over 1,000 new cases/year. The percentage of patients treated at FAPTP centers grew from 30% to 57% with an annual percentage change (APC) of 10.3% (95% Confidence Interval [CI] of 0.6 to 20.9%). The rate of COG clinical trial enrollment decreased from 32% in 1981-1985 to 20% in 2016-2020, for an APC of 8.91% (95% CI of -13.3 to -4.3%). Conclusions The striking increase in pediatric cancer cases in Florida over the last 40 years was out of proportion to the population growth. More patients received care at FAPTP centers, but a lower percentage were enrolled on COG trials.

Identifiants

pubmed: 36938203
doi: 10.7759/cureus.35061
pmc: PMC10023130
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e35061

Informations de copyright

Copyright © 2023, Shaw et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Pediatr Blood Cancer. 2017 Dec;64(12):
pubmed: 28509440
J Clin Oncol. 2010 May 20;28(15):2625-34
pubmed: 20404250
PLoS One. 2020 Apr 23;15(4):e0230824
pubmed: 32324751
J Pediatr Hematol Oncol. 2007 Dec;29(12):811-4
pubmed: 18090927
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Cancer. 1992 Apr 15;69(8):2212-9
pubmed: 1544126
Cancer. 1993 May 15;71(10 Suppl):3331-6
pubmed: 8490877
Pediatr Blood Cancer. 2010 Apr;54(4):511-8
pubmed: 20054842
Cancer. 2016 Sep 15;122(18):2867-75
pubmed: 27351365
Cancer. 2009 Aug 15;115(16):3808-16
pubmed: 19484783
MMWR Morb Mortal Wkly Rep. 2018 Jun 29;67(25):707-713
pubmed: 29953430
J Clin Oncol. 2012 Jun 1;30(16):2005-12
pubmed: 22547602
J Fla Med Assoc. 1993 Nov;80(11):747-51
pubmed: 8277234
Cancer. 2021 Oct 1;127(19):3651-3663
pubmed: 34151418
Cancer. 2001 Apr 1;91(7):1402-8
pubmed: 11283943

Auteurs

Peter H Shaw (PH)

Pediatrics/Oncology, Children's Wisconsin/Medical College of Wisconsin, Milwaukee, USA.

Jonathan Metts (J)

Pediatric Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, USA.

Ernest Amankwah (E)

Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, USA.

Don E Eslin (DE)

Pediatric Oncology, St. Joseph's Children's Hospital, Tampa, USA.

Scott Bradfield (S)

Pediatric Oncology, Nemours Children's Health System, Jacksonville, USA.

William B Slayton (WB)

Pediatric Oncology, University of Florida College of Medicine, Gainesville, USA.

Brian Hays (B)

Epidemiology, University of South Florida Morsani College of Medicine, Tampa, USA.

Brian Calkins (B)

Epidemiology, University of South Florida Morsani College of Medicine, Tampa, USA.

Juan Rico (J)

Pediatric Hematology Oncology, University of South Florida Morsani College of Medicine, Tampa, USA.

Jeffrey Krischer (J)

Epidemiology and Biostatistics, University of South Florida Morsani College of Medicine, Tampa, USA.

Classifications MeSH